Business

Novo Nordisk's Corporate Strategy Update

Updated 2026-09-14 13:40 UTC 1 source Neutral

MarketWatch reports that Novo Nordisk is changing its corporate name from ‘Nordisk’ to focus on weight-loss drug competition with Eli Lilly. The move aims to strengthen its market position in the weight-loss drugs sector.

Coverage timeline — 1 article

MarketWatch

Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars

The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.

2026-09-14 13:20 UTC